69 reports of this reaction
1.6% of all ALUMINUM HYDROXIDE reports
#9 most reported adverse reaction
SOMNOLENCE is the #9 most commonly reported adverse reaction for ALUMINUM HYDROXIDE, manufactured by Rugby Laboratories. There are 69 FDA adverse event reports linking ALUMINUM HYDROXIDE to SOMNOLENCE. This represents approximately 1.6% of all 4,296 adverse event reports for this drug.
Patients taking ALUMINUM HYDROXIDE who experience somnolence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SOMNOLENCE is a less commonly reported adverse event for ALUMINUM HYDROXIDE, but still significant enough to appear in the safety profile.
In addition to somnolence, the following adverse reactions have been reported for ALUMINUM HYDROXIDE:
The following drugs have also been linked to somnolence in FDA adverse event reports:
SOMNOLENCE has been reported as an adverse event in 69 FDA reports for ALUMINUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SOMNOLENCE accounts for approximately 1.6% of all adverse event reports for ALUMINUM HYDROXIDE, making it a notable side effect.
If you experience somnolence while taking ALUMINUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.